024890 — Daewon Chemical Co Income Statement
0.000.00%
Last trade - 00:00
- KR₩61bn
- KR₩118bn
- KR₩122bn
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 133,053 | 108,787 | 113,339 | 146,805 | 122,178 |
Cost of Revenue | |||||
Gross Profit | 26,457 | 17,387 | 13,633 | 16,764 | 13,693 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 127,832 | 109,689 | 121,770 | 154,206 | 128,615 |
Operating Profit | 5,221 | -902 | -8,431 | -7,401 | -6,436 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 5,173 | -1,700 | -8,561 | -8,982 | -9,181 |
Provision for Income Taxes | |||||
Net Income After Taxes | 4,279 | -2,183 | -7,004 | -9,622 | -9,745 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 4,286 | -2,175 | -7,006 | -9,632 | -9,745 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 4,286 | -2,175 | -7,006 | -9,632 | -9,745 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 134 | -38.2 | -173 | -237 | -239 |
Dividends per Share |